advanced OC
Showing 26 - 50 of >10,000
Advanced Epithelial Ovarian Cancer Trial in Cairo (Carboplatin/paclitaxel)
Completed
- Advanced Epithelial Ovarian Cancer
-
Cairo, EgyptPharmacology and toxicology department, Faculty of Pharmacy, Cai
Jul 19, 2023
Glioblastoma Trial in Canada, China, United States (drug, other, radiation)
Active, not recruiting
- Glioblastoma
- Enzastaurin Hydrochloride
- +3 more
-
Birmingham, Alabama
- +62 more
Oct 11, 2022
Anorexia Nervosa, OCD, Social Phobia Trial in Saint Louis (Radically Open Dialectical Behavior Therapy (RO DBT))
Completed
- Anorexia Nervosa
- +3 more
- Radically Open Dialectical Behavior Therapy (RO DBT)
-
Saint Louis, MissouriWashington University School of Medicine
Jun 12, 2023
Ovarian Cancer Stage IV Trial in France (Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab, Chemotherapy -
Active, not recruiting
- Ovarian Cancer Stage IV
- Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
- Chemotherapy - Bevacizumab
-
Avignon, France
- +16 more
Feb 15, 2022
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
Ovarian Cancer Trial in Helsinki (Biomolecular profiling)
Recruiting
- Ovarian Cancer
- Biomolecular profiling
-
Helsinki, FinlandHelsinki University and Helsinki University Hospital
Nov 1, 2023
Psoriasis Trial in Worldwide (Apremilast (CC-10004), Placebo)
Active, not recruiting
- Psoriasis
- Apremilast (CC-10004)
- Placebo
-
Birmingham, Alabama
- +98 more
Nov 10, 2022
Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo, Topical Corticosteroid)
Completed
- Atopic Dermatitis
- Lebrikizumab
- +2 more
-
Scottsdale, Arizona
- +62 more
May 5, 2022
Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)
Recruiting
- Renal Cell Carcinoma
- +4 more
- SHR-1210
- Famitinib
-
Shanghai, Shanghai, ChinaHuadong Hospital Affiliated to Fudan University
Jun 30, 2022
Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)
Recruiting
- Advanced Malignancies
- BI-1808
- Pembrolizumab 25 Mg/mL Solution for Injection
-
Copenhagen, Denmark
- +11 more
Sep 9, 2022
Colonic Polyp Trial in United States (Capsule Endoscope)
Recruiting
- Colonic Polyp
- Capsule Endoscope
-
Scottsdale, Arizona
- +10 more
Nov 8, 2022
Removal of Ovaries/Fallopian Tubes and CA-125 Screening to
Completed
- Breast Cancer
- Ovarian Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,
Recruiting
- Metastatic Ovarian Cancer
- +2 more
- Ipilimumab
- +5 more
-
Herlev, DenmarkNational Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021
Fecal Immunochemical Test for Post-polypectomy Surveillance to
Recruiting
- Colorectal Neoplasms
-
Calgary, Alberta, CanadaForzani & Macphail Colon Cancer Screening Centre, University of
May 24, 2022
Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)
Recruiting
- Breast Cancer
- Ribociclib
- +2 more
-
Prato, Please Select:, ItalyHospital of Prato
Jul 27, 2022
Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)
Recruiting
- Chronic Spontaneous Urticaria
- Tezepelumab Dose 1
- +3 more
-
Birmingham, Alabama
- +81 more
Aug 4, 2022
Peripherally Inserted Central Catheter Trial in Beijing (Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC
Recruiting
- Peripherally Inserted Central Catheter
- Arrowga+rd Blue Advance Protection PICC Placement
- Sham Comparator PICC placement
-
Beijing, Doncheng District, China
- +4 more
Jan 20, 2023
Colon Cancer, Rectum Cancer Trial in France (optical colonoscopy, colon capsule endoscopy, fecal immunological test (FIT))
Recruiting
- Colon Cancer
- Rectum Cancer
- optical colonoscopy
- +2 more
-
Colmar, Alsace, France
- +18 more
Mar 14, 2022